150 related articles for article (PubMed ID: 32647207)
21. Improved grading and survival prediction of human astrocytic brain tumors by artificial neural network analysis of gene expression microarray data.
Petalidis LP; Oulas A; Backlund M; Wayland MT; Liu L; Plant K; Happerfield L; Freeman TC; Poirazi P; Collins VP
Mol Cancer Ther; 2008 May; 7(5):1013-24. PubMed ID: 18445660
[TBL] [Abstract][Full Text] [Related]
22. Comparative transcriptomics reveals similarities and differences between astrocytoma grades.
Seifert M; Garbe M; Friedrich B; Mittelbronn M; Klink B
BMC Cancer; 2015 Dec; 15():952. PubMed ID: 26673168
[TBL] [Abstract][Full Text] [Related]
23. Screening critical genes associated with malignant glioma using bioinformatics analysis.
Xu Y; Wang J; Xu Y; Xiao H; Li J; Wang Z
Mol Med Rep; 2017 Nov; 16(5):6580-6589. PubMed ID: 28901452
[TBL] [Abstract][Full Text] [Related]
24. Three meta-analyses define a set of commonly overexpressed genes from microarray datasets on astrocytomas.
Liu Z; Xie M; Yao Z; Niu Y; Bu Y; Gao C
Mol Neurobiol; 2013 Feb; 47(1):325-36. PubMed ID: 23135747
[TBL] [Abstract][Full Text] [Related]
25. Identification of novel genes associated with astrocytoma progression using suppression subtractive hybridization and real-time reverse transcription-polymerase chain reaction.
van den Boom J; Wolter M; Blaschke B; Knobbe CB; Reifenberger G
Int J Cancer; 2006 Nov; 119(10):2330-8. PubMed ID: 16865689
[TBL] [Abstract][Full Text] [Related]
26. High CHI3L1 expression is associated with glioma patient survival.
Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
[TBL] [Abstract][Full Text] [Related]
27. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
[TBL] [Abstract][Full Text] [Related]
28. Gene expression profiling of human gliomas reveals differences between GBM and LGA related to energy metabolism and notch signaling pathways.
Margareto J; Leis O; Larrarte E; Idoate MA; Carrasco A; Lafuente JV
J Mol Neurosci; 2007; 32(1):53-63. PubMed ID: 17873288
[TBL] [Abstract][Full Text] [Related]
29. Progression-associated genes in astrocytoma identified by novel microarray gene expression data reanalysis.
MacDonald TJ; Pollack IF; Okada H; Bhattacharya S; Lyons-Weiler J
Methods Mol Biol; 2007; 377():203-22. PubMed ID: 17634619
[TBL] [Abstract][Full Text] [Related]
30. Identification of COL6A1 as a differentially expressed gene in human astrocytomas.
Fujita A; Sato JR; Festa F; Gomes LR; Oba-Shinjo SM; Marie SK; Ferreira CE; Sogayar MC
Genet Mol Res; 2008 Apr; 7(2):371-8. PubMed ID: 18551403
[TBL] [Abstract][Full Text] [Related]
31. Profiling of novel circulating microRNAs as a non-invasive biomarker in diagnosis and follow-up of high and low-grade gliomas.
Tabibkhooei A; Izadpanahi M; Arab A; Zare-Mirzaei A; Minaeian S; Rostami A; Mohsenian A
Clin Neurol Neurosurg; 2020 Mar; 190():105652. PubMed ID: 31896490
[TBL] [Abstract][Full Text] [Related]
32. Identification of necrosis-associated genes in glioblastoma by cDNA microarray analysis.
Raza SM; Fuller GN; Rhee CH; Huang S; Hess K; Zhang W; Sawaya R
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):212-21. PubMed ID: 14734472
[TBL] [Abstract][Full Text] [Related]
33. Microsomal membrane proteome of low grade diffuse astrocytomas: Differentially expressed proteins and candidate surveillance biomarkers.
Polisetty RV; Gautam P; Gupta MK; Sharma R; Gowda H; Renu D; Shivakumar BM; Lakshmikantha A; Mariswamappa K; Ankathi P; Purohit AK; Uppin MS; Sundaram C; Sirdeshmukh R
Sci Rep; 2016 Jun; 6():26882. PubMed ID: 27246909
[TBL] [Abstract][Full Text] [Related]
34. Molecular pathogenesis of pediatric astrocytic tumors.
Nakamura M; Shimada K; Ishida E; Higuchi T; Nakase H; Sakaki T; Konishi N
Neuro Oncol; 2007 Apr; 9(2):113-23. PubMed ID: 17327574
[TBL] [Abstract][Full Text] [Related]
35. Differentiating diffuse World Health Organization grade II and IV astrocytomas with ex vivo magnetic resonance spectroscopy.
Vettukattil R; Gulati M; Sjøbakk TE; Jakola AS; Kvernmo NA; Torp SH; Bathen TF; Gulati S; Gribbestad IS
Neurosurgery; 2013 Feb; 72(2):186-95; discussion 195. PubMed ID: 23147779
[TBL] [Abstract][Full Text] [Related]
36. Copy Number Profiling of Brazilian Astrocytomas.
Bidinotto LT; Torrieri R; Mackay A; Almeida GC; Viana-Pereira M; Cruvinel-Carloni A; Spina ML; Campanella NC; Pereira de Menezes W; Clara CA; Becker AP; Jones C; Reis RM
G3 (Bethesda); 2016 Jul; 6(7):1867-78. PubMed ID: 27172220
[TBL] [Abstract][Full Text] [Related]
37. [Study on the expression of epidermal growth factor receptor and p53 in astrocytic gliomas: evidence for a distinct genetic pathway].
Dong L; Pu PY; Wang H; Wang GX; Kang CS; Jiao DR
Zhonghua Bing Li Xue Za Zhi; 2006 Apr; 35(4):232-6. PubMed ID: 16776982
[TBL] [Abstract][Full Text] [Related]
38. Identification of histological markers for malignant glioma by genome-wide expression analysis: dynein, alpha-PIX and sorcin.
Yokota T; Kouno J; Adachi K; Takahashi H; Teramoto A; Matsumoto K; Sugisaki Y; Onda M; Tsunoda T
Acta Neuropathol; 2006 Jan; 111(1):29-38. PubMed ID: 16320026
[TBL] [Abstract][Full Text] [Related]
39. IDH-mutated astrocytomas with 19q-loss constitute a subgroup that confers better prognosis.
Otani R; Uzuka T; Higuchi F; Matsuda H; Nomura M; Tanaka S; Mukasa A; Ichimura K; Kim P; Ueki K
Cancer Sci; 2018 Jul; 109(7):2327-2335. PubMed ID: 29752851
[TBL] [Abstract][Full Text] [Related]
40. Gene expression profiling identifies molecular subtypes of gliomas.
Shai R; Shi T; Kremen TJ; Horvath S; Liau LM; Cloughesy TF; Mischel PS; Nelson SF
Oncogene; 2003 Jul; 22(31):4918-23. PubMed ID: 12894235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
